Stimulated Raman histology, a novel method to allow for rapid pathologic examination of unprocessed, fresh prostate biopsies
Authors:
Open Access
- 8 May 2023
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 83 (11) , 1060-1067
Abstract
Introduction: Delay between targeted prostate biopsy (PB) and pathologic diagnosis can lead to a concern of inadequate sampling and repeated biopsy. Stimulated Raman histology (SRH) is a novel microscopic technique allowing real‐time, label‐free, high‐resolution microscopic images of unprocessed, unsectioned tissue. This technology holds potential to decrease the time for PB diagnosis from days to minutes. We evaluated the concordance of pathologist interpretation of PB SRH as compared with traditional hematoxylin and eosin (H&E) stained slides.Methods: Men undergoing prostatectomy were included in an IRB‐approved prospective study. Ex vivo 18‐gauge PB cores, taken from prostatectomy specimen, were scanned in an SRH microscope (NIO; Invenio Imaging) at 20 microns depth using two Raman shifts: 2845 and 2930 cm−1, to create SRH images. The cores were then processed as per normal pathologic protocols. Sixteen PB containing a mix of benign and malignant histology were used as an SRH training cohort for four genitourinary pathologists, who were then tested on a set of 32 PBs imaged by SRH and processed by traditional H&E. Sensitivity, specificity, accuracy, and concordance for prostate cancer (PCa) detection on SRH relative to H&E were assessed.Results: The mean pathologist accuracy for the identification of any PCa on PB SRH was 95.7%. In identifying any PCa or ISUP grade group 2–5 PCa, a pathologist was independently able to achieve good and very good concordance (κ: 0.769 and 0.845, respectively; p < 0.001). After individual assessment was completed a pathology consensus conference was held for the interpretation of the PB SRH; after the consensus conference the pathologists' concordance in identifying any PCa was also very good (κ: 0.925, p < 0.001; sensitivity 95.6%; specificity 100%).Conclusion: SRH produces high‐quality microscopic images that allow for accurate identification of PCa in real‐time without need for sectioning or tissue processing. The pathologist performance improved through progressive training, showing that ultimately high accuracy can be obtained. Ongoing SRH evaluation in the diagnostic and treatment setting hold promise to reduce time to tissue diagnosis, while interpretation by convolutional neural network may further improve diagnostic characteristics and broaden use.Keywords
Funding Information
- National Institutes of Health
This publication has 13 references indexed in Scilit:
- Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate BiopsyJournal of Urology, 2021
- Diagnosing 12 prostate needle cores within an hour of biopsy via open-top light-sheet microscopyJournal of Biomedical Optics, 2020
- An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment studyThe Lancet Digital Health, 2020
- Intraoperative assessment and reporting of radical prostatectomy specimens to guide nerve‐sparing surgery in prostate cancer patients (NeuroSAFE)Histopathology, 2020
- The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic CarcinomaAmerican Journal of Surgical Pathology, 2020
- Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networksNature Medicine, 2020
- What is an acceptable false negative rate in the detection of prostate cancer?Translational Andrology and Urology, 2018
- Rapid intraoperative histology of unprocessed surgical specimens via fibre-laser-based stimulated Raman scattering microscopyNature Biomedical Engineering, 2017
- Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer AggressivenessCell Metabolism, 2014
- Interobserver reproducibility of Gleason grading of prostatic carcinoma: General pathologistHuman Pathology, 2001